Anti-HIV Medications for People Recently Infected With HIV
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
It is not known if anti-HIV treatment for recently infected patients improves long-term
patient prognosis. The purpose of this study is to determine if a one year course of anti-HIV
medications slows progression of HIV disease in adults recently infected with HIV.
Study hypothesis: A one-year course of HAART administered during acute or early
seroconversion may slow the progression of HIV infection.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)